　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Notice of Drug Clinical Trial Approval from the ...

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

Detailed>>

Detailed +

2022.01

2022.01.22

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passe...

　　CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval...

2021.11

2021.11.12

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone and CR Double-Crane Convened

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony ...

　　At 9: 00 on November 11, 2021, a novel cancer drug was released by CR Double-Crane, and the signing ceremony between the company and...

2021.10

2021.10.09

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

2021.10

2021.10.08

A Delegation Led by Zhang Boli Visiting CR Sanjiu

　　On October 7, a delegation led by Zhang Boli, an academician with the Chinese Academy of Engineering and recipient of the national h...

2021.09

2021.09.17

Remaining Committed to Charity - The CR Healthy Village Program Keeping up the Good Work

Remaining Committed to Charity - The CR Healthy Village Program Keeping...

　　The meeting for wrapping up the CR Healthy Village Program with the theme of “Boosting Primary-Level Medical Services and Supportin...

2021.08

2021.08.04

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chlo...

　　On August 4, CR Double-Crane issued an announcement that the Sodium Valproate Tablets produced by Hunan Xiangzhong Pharmaceutical Co...

2021.07

2021.07.21

CR Double-Crane and NOVITA signed an exclusive license agreement on the development, production and commercialization of NP-G2-044 Fascin inhibitor in Greater China.

CR Double-Crane and NOVITA signed an exclusive license agreement on the...

　　On July 21, CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane), a subsidiary of China Resources P...